DOI : 10.1055/s-00000094

Zeitschrift für Gastroenterologie

Ausgabe 01 · Volume 59 · Januar 2021 DOI: 10.1055/s-011-50135

Deutsche Arbeitsgemeinschaft zum Studium der Leber
37. Jahrestagung der Deutschen Arbeitsgemeinschaft zum Studium der Leber
Münster, 29.-30.01.2021

Kongresspräsident: Prof. Dr. Andreas Pascher
Abstracts (HTML) Abstracts (PDF) Autorenliste
5.8
Müller, AL; Casar, C; Krzikalla, D; Preti, M; Bronowski, C; Krause, J; Gelderblom, M; Altfeld, M; Schwinge, D; Lohse, AW; Schramm, C; Carambia, A; Herkel, J: Inflammatory type 2 conventional dendritic cells contribute to cholangitis in mice
5.9
Rumer, C; Jonin, F; Tiegs, G; Neumann, K: Characterization of murine monocyte and macrophage subsets in immune-mediated hepatitis
5.10
Rufinatscha, K; Stindt, S; Luedde, T; Bode, JG: IL-1β and TNFα enhance the CXC chemokine expression of Hepatitis C Virus infected cells
5.11
Kellerer, M; Tiegs, G; Horst, AK; Schramm, C: Soluble CEACAM1 induces suppressive Tregs and binds to CD5 in a heterophilic manner
5.12
Pfefferkorn, M; Deichsel, D; Matz-Soja, M; Berg, T; van Bömmel, F: Deletions in the HBV s gene are associated with altered HBsAg composition in patients with HBsAg loss during NA therapy
5.13
Kupke, P; Adenugba, A; Schemmerer, M; Hornung, M; Schlitt, HJ; Geissler, EK; Wenzel, JJ; Werner, JM: Immunomodulation of NK cells by Ribavirin is driven by pSTAT-4 activation with increased IFN-γ secretion in HEV
5.14
Ehlting, C; Hahnel, MJ; Skryabin, A; Wolf, SD; Gaestel, M; Luedde, T; Bode, JG: MAPKAPK 2 impedes hepcidin mRNA expression and maintains iron availability in response to bacterial endotoxins
5.15
Ehlting, C; Gaestel, M; Luedde, T; Bode, JG: MAPKAPK 2 and 3 promote viral replication and resolution of intrahepatic myeloid-cell aggregates upon CMV infection
5.16
Bulankina, AV; Stroß, C; Wood, D; Grimm, C; Charif, H; Richter, RM; Chen, W; Zeuzem, S; Biondi, RM; Kudryashev, M; Welsch, C: Interactions with phospholipids and membrane remodeling by nonstructural protein 5A of hepatitis C virus
5.17
Bockmann, JH; Allweiss, L; Volz, T; Giersch, K; Ladiges, Y; Pirosu, A; Lohse, AW; Lütgehetmann, M; Dandri, M: A cell culture model of high HBV replication in primary human hepatocytes derived from HBV infected humanized mice
5.18
Aliabadi, E; Wedemeyer, H; Kraft, ARM; Cornberg, M: Characterization of in-vitro responses to immune modulation of HBV core18-specific vs HBV pol455-specific CD8+ T cells
5.19
Wieland, B; Bartels, C; Wolf, SD; Luedde, T; Ehlting, C; Bode, JG: Impact of intercellular communication between macrophages and hepatocytes on their responses towards CMV or LPS
5.20
Wang, C; Xu, P; Wang, G; Wang, H; Zhang, Y; Billiar, T; Zhang, J: TLR4 KO MSC optimized protection in liver IRI via CXCR2/CXCL2-mediated crosstalk with Kupffer cells
5.21
Peschel, G; Grimm, J; Gunckel, M; Pollinger, K; Aschenbrenner, E; Gülow, K; Müller-Schilling, M; Weigand, K: Decline of liver stiffness in patients with HCV under DAA therapy is associated with decrease of inflammation markers
5.22
Oberhardt, V; Hofmann, M; Thimme, R; Neumann-Haefelin, C: Discovery of conserved HDV-specific CD8+ T-cell epitopes in HBV/HDV infection
5.23
Pflüger, LS; Giersch, K; Nörz, D; Volz, T; Goldmann, N; Giese, A; Pfefferle, S; Bockmann, J; Glebe, D; Dandri, M; Schulze zur Wiesch, J; Lütgehetmann, M: Clinical establishment of a Laboratory Developed quantitative HDV PCR assay on the cobas 6800 high-throughput system